Literature DB >> 21070813

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

Gonzalo Yebra1, Miguel de Mulder, Leticia Martín, Santiago Pérez-Cachafeiro, Carmen Rodríguez, Pablo Labarga, Federico García, Cristina Tural, Angels Jaén, Gemma Navarro, A Holguín.   

Abstract

BACKGROUND: HIV-1 group M is classified into 9 subtypes and recombinants (CRFs/URFs). Variants other than subtype B (non-B) cause 90% of infections worldwide. HIV is often subtyped using automated tools instead of the gold-standard phylogenetic analysis. We evaluated the reliability of subtyping tools vs. phylogeny in a panel of HIV-1 pol sequences from the cohort of naïve patients of the HIV/AIDS Spanish Research Network (CoRIS).
METHODS: HIV-1 subtyping was performed using seven automated subtyping tools (Stanford, Geno2pheno, Rega, NCBI, EuResist, STAR, TherapyEdge) in HIV-1 pol sequences from 670 CoRIS patients previously subtyped by phylogeny (587 subtype B/83 non-B). Sensitivity with respect to phylogeny was assessed.
RESULTS: Most tools correctly classified subtype B, although up to 15% of non-B sequences were wrongly identified as B depending on the tool. For subtype B and CRF02_AG identification, Stanford/NCBI and Geno2pheno/Rega presented the highest/lowest sensitivities, respectively. EuResist and Geno2pheno correctly classified all 13 non-B "pure"subtypes at pol. The efficacy of all subtyping tools dropped clearly when identifying recombinants different from CRF02_AG. Only NCBI05, Rega and STAR identified URF, but with very low sensitivities. NCBI classified the highest number of subtypes B as non-B, and overestimated recombinants, especially when including references of 2009.
CONCLUSIONS: Automated tools are useful for subtype B identification, although they present serious limitations in classifying variants uncommon in developed regions, especially recombinants. Their sensitivity depends on the prevalence of non-B variants in the population, and decreases drastically when the frequency of recombinants increases. Furthermore, HIV-1 variant distribution differs according to the tool used.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070813     DOI: 10.1016/j.antiviral.2010.10.008

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya.

Authors:  Timothy J Nzomo; Rose C Kitawi; Ruth S Mwatelah; Rashid Aman; Maureen J Kimulwo; Geoffrey Masankwa; Javan Okendo; Raphael M Lwembe; Bernhards Ogutu; Anne Muigai; Washingtone Ochieng
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-31       Impact factor: 2.205

2.  Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.

Authors:  Lavinia Fabeni; Giulia Berno; Joseph Fokam; Ada Bertoli; Claudia Alteri; Caterina Gori; Federica Forbici; Desiré Takou; Alessandra Vergori; Mauro Zaccarelli; Gaetano Maffongelli; Vanni Borghi; Alessandra Latini; Alfredo Pennica; Claudio Maria Mastroianni; Francesco Montella; Cristina Mussini; Massimo Andreoni; Andrea Antinori; Carlo Federico Perno; Maria Mercedes Santoro
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island.

Authors:  Philip A Chan; Marissa B Reitsma; Allison DeLong; Bruce Boucek; Amy Nunn; Marco Salemi; Rami Kantor
Journal:  Infect Genet Evol       Date:  2014-04-08       Impact factor: 3.342

4.  Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States.

Authors:  Michael T Pyne; John Hackett; Vera Holzmayer; David R Hillyard
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

5.  HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Authors:  Rami Kantor; Allison DeLong; Maya Balamane; Leeann Schreier; Robert M Lloyd; Wilfred Injera; Lydia Kamle; Fidelis Mambo; Sarah Muyonga; David Katzenstein; Joseph Hogan; Nathan Buziba; Lameck Diero
Journal:  J Int AIDS Soc       Date:  2014-11-18       Impact factor: 5.396

6.  HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.

Authors:  Ana B Abecasis; Annemarie M J Wensing; Dimitris Paraskevis; Jurgen Vercauteren; Kristof Theys; David A M C Van de Vijver; Jan Albert; Birgitta Asjö; Claudia Balotta; Danail Beshkov; Ricardo J Camacho; Bonaventura Clotet; Cillian De Gascun; Algis Griskevicius; Zehava Grossman; Osamah Hamouda; Andrzej Horban; Tatjana Kolupajeva; Klaus Korn; Leon G Kostrikis; Claudia Kücherer; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elisabeth Puchhammer-Stöckl; Jean-Claude Schmit; Anders Sönnerborg; Danika Stanekova; Maja Stanojevic; Daniel Struck; Charles A B Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2013-01-14       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.